Name | Number of supported studies | Average coverage | |
---|---|---|---|
adipocyte | 8 studies | 29% ± 6% | |
plasma cell | 3 studies | 25% ± 10% | |
pro-B cell | 3 studies | 25% ± 5% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 3 studies | 23% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
skin | 98% | 2928.77 | 1772 / 1809 | 93% | 5.00 | 439 / 472 |
thymus | 97% | 1955.77 | 633 / 653 | 93% | 2.62 | 565 / 605 |
adrenal gland | 98% | 1779.69 | 252 / 258 | 89% | 3.70 | 205 / 230 |
breast | 100% | 8308.98 | 457 / 459 | 83% | 2.77 | 929 / 1118 |
lung | 99% | 2737.48 | 571 / 578 | 65% | 1.58 | 748 / 1155 |
brain | 60% | 769.85 | 1578 / 2642 | 96% | 3.65 | 677 / 705 |
esophagus | 84% | 1727.47 | 1211 / 1445 | 66% | 1.63 | 120 / 183 |
intestine | 94% | 1839.44 | 906 / 966 | 47% | 1.01 | 250 / 527 |
bladder | 100% | 1947.57 | 21 / 21 | 36% | 0.82 | 179 / 504 |
uterus | 94% | 2065.25 | 159 / 170 | 39% | 0.98 | 179 / 459 |
ovary | 98% | 2137.51 | 177 / 180 | 30% | 0.59 | 128 / 430 |
stomach | 65% | 1024.82 | 234 / 359 | 58% | 1.50 | 167 / 286 |
liver | 62% | 805.37 | 140 / 226 | 42% | 0.80 | 170 / 406 |
prostate | 68% | 957.87 | 167 / 245 | 33% | 0.53 | 165 / 502 |
adipose | 100% | 10116.55 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 10.65 | 29 / 29 |
spleen | 100% | 3308.77 | 241 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 3232.57 | 1332 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 98% | 3.87 | 78 / 80 |
peripheral blood | 92% | 3177.66 | 852 / 929 | 0% | 0 | 0 / 0 |
heart | 91% | 1593.53 | 786 / 861 | 0% | 0 | 0 / 0 |
pancreas | 9% | 74.94 | 28 / 328 | 74% | 1.97 | 132 / 178 |
kidney | 29% | 372.79 | 26 / 89 | 51% | 1.55 | 463 / 901 |
tonsil | 0% | 0 | 0 / 0 | 80% | 2.31 | 36 / 45 |
muscle | 41% | 468.34 | 330 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0008360 | Biological process | regulation of cell shape |
GO_0090150 | Biological process | establishment of protein localization to membrane |
GO_0007010 | Biological process | cytoskeleton organization |
GO_0007097 | Biological process | nuclear migration |
GO_0034993 | Cellular component | meiotic nuclear membrane microtubule tethering complex |
GO_0005791 | Cellular component | rough endoplasmic reticulum |
GO_0031965 | Cellular component | nuclear membrane |
GO_0005640 | Cellular component | nuclear outer membrane |
GO_0005635 | Cellular component | nuclear envelope |
GO_0016020 | Cellular component | membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0140444 | Molecular function | cytoskeleton-nuclear membrane anchor activity |
GO_0051015 | Molecular function | actin filament binding |
GO_0005515 | Molecular function | protein binding |
Gene name | SYNE3 |
Protein name | Nesprin-3 (KASH domain-containing protein 3) (KASH3) (Nuclear envelope spectrin repeat protein 3) Spectrin repeat containing nuclear envelope family member 3 |
Synonyms | C14orf139 LINC00341 C14orf49 |
Description | FUNCTION: As a component of the LINC (LInker of Nucleoskeleton and Cytoskeleton) complex involved in the connection between the nuclear lamina and the cytoskeleton. The nucleocytoplasmic interactions established by the LINC complex play an important role in the transmission of mechanical forces across the nuclear envelope and in nuclear movement and positioning. Probable anchoring protein which tethers the nucleus to the cytoskeleton by binding PLEC which can associate with the intermediate filament system. Plays a role in the regulation of aortic epithelial cell morphology, and is required for flow-induced centrosome polarization and directional migration in aortic endothelial cells. . |
Accessions | Q6ZMZ3 ENST00000554873.5 ENST00000334258.9 [Q6ZMZ3-1] G3V533 ENST00000682763.1 [Q6ZMZ3-1] ENST00000553340.1 [Q6ZMZ3-3] ENST00000557275.5 [Q6ZMZ3-2] |